# Studying Biomarkers as a Diagnostic Tool in Samples From Younger Patients With B-Cell Acute Lymphoblastic Leukemia

> **NCT01540578** · — · COMPLETED · sponsor: **Children's Oncology Group** · enrollment: 70 (actual)

## Conditions studied

- B-cell Childhood Acute Lymphoblastic Leukemia
- Childhood Acute Lymphoblastic Leukemia in Remission
- Recurrent Childhood Acute Lymphoblastic Leukemia

## Interventions

- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT01540578
- **Lead sponsor:** Children's Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2016-05
- **Final completion:** —
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2016-05-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01540578

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01540578, "Studying Biomarkers as a Diagnostic Tool in Samples From Younger Patients With B-Cell Acute Lymphoblastic Leukemia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01540578. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*